Our Solutions for Insect Control
Ginkgo’s R&D services support your product development to enable your market entry, growth, and strategic goals.
Ginkgo’s R&D services support your product development to enable your market entry, growth, and strategic goals.
Launch new disease control products using Ginkgo as your R&D engine.
Your Starting Point
The insect or spectrum you want your next product to target
What We Offer: Product co-development from lab to field
Why Ginkgo
Our team begins with the end in mind. We know that insect control biologicals must be grower-friendly: potent, easy to use, and price-competitive.
Get Started
Contact us, and we’ll schedule a call to answer your questions.
Improve efficacy of your existing products or lead candidates
Your Starting Point
Your bioinsecticide product or your lead candidates
What We Offer: Optimization approaches tailored to your manufacturing and regulatory constraints
Why Ginkgo
Our team applies high and ultra-high-throughput methods to media optimization and non-GM strain optimization. Optimize your product’s performance, quickly.
Get Started
Contact us, and we’ll schedule a call to answer your questions.
Access new markets through processes and inputs tailored to your manufacturing constraints
Your Starting Point
Your bioinsecticide product or your lead candidates
What We Offer: Process optimization and scale-up
Why Ginkgo
Our team has deep expertise in fermentation and formulation for gram-positive strains. Test new processes from lab to pilot scale all under one roof.
Get Started
Contact us, and we’ll schedule a call to answer your questions.
Validate lead candidates using robust in vitro and in planta screening cascades
Your Starting Point
Your bioinsecticide lead candidates
What We Offer: Screening and selection
Why Ginkgo
We’ve developed and validated in vitro and in planta assays across a broad spectrum of insects and crops. Rigorous science drives better biologicals.
Our team is excited to learn how Ginkgo can accelerate your product development goals. Start the conversation today.